Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  recombinant human interleukin-15
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Recombinant Human Interleukin-15 and Donor Natural Killer Cell Infusion in Treating Patients with Refractory or Relapsed Acute Myelogenous Leukemia
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 9880, NCI-2015-00396, 2014LS092, P9880, NCT02395822
Recombinant Human Interleukin-15 in Treating Patients with Metastatic or Unresectable Cancer
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0113, NCI-2013-01520, 120113, P11905, NCT01572493
Recombinant Human Interleukin-15 and Alemtuzumab in Treating Patients with Refractory or Relapsed Chronic or Acute Adult T-Cell Leukemia
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-C-0062, NCI-2016-00195, P152447, 10004, NCT02689453
Start Over